I overensstemmelse med gængs klinisk praksis skal seponering af Zonegran hos patienter med epilepsi ske ved gradvis dosisreduktion for at reducere risikoen for kramper i forbindelse med seponering.
In accordance with current clinical practice, discontinuation of Zonegran in patients with epilepsy must be accomplished by gradual dose reduction, to reduce the possibility of seizures on withdrawal.